Optimized Implementation of cardiac resynchronization therapy - a call for action for referral and optimization of care.

Implementation Cardiac resynchronization therapy Care pathways Disease Modification Disease management Heart failure Outcome Response Utilization

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
05 Feb 2021
Historique:
accepted: 28 01 2021
entrez: 5 2 2021
pubmed: 6 2 2021
medline: 6 2 2021
Statut: aheadofprint

Résumé

Cardiac resynchronization therapy (CRT) is one of the most effective therapies for heart failure with reduced ejection fraction and leads to improved quality of life, reductions in heartfailure hospitalization rates and reduces all-cause mortality. Nevertheless, up to two-thirds ofeligible patients are not referred for CRT. Furthermore, post implantation follow-up is oftenfragmented and suboptimal, hampering the potential maximal treatment effect. This jointposition statement from three ESC Associations, HFA, EHRA and EACVI focuses onoptimized implementation of CRT. We offer theoretical and practical strategies to achievemore comprehensive CRT referral and post-procedural care by focusing on four actionabledomains; (I) overcoming CRT under-utilization, (II) better understanding of pre-implantcharacteristics, (III) abandoning the term 'non-response' and replacing this by the concept ofdisease modification, and (IV) implementing a dedicated post-implant CRT care pathway.

Identifiants

pubmed: 33544835
pii: 6129260
doi: 10.1093/europace/euab035
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2021. For permissions, please email: journals.permissions@oup.com.

Auteurs

Wilfried Mullens (W)

Ziekenhuis Oost Limburg, Genk, - University Hasselt, Hasselt, both in Belgium.

Angelo Auricchio (A)

Division of Cardiology, Cardiocentro Ticino, Lugano, Switzerland.

Pieter Martens (P)

Ziekenhuis Oost Limburg, Genk, - University Hasselt, Hasselt, both in Belgium.

Klaus Witte (K)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.

Martin R Cowie (MR)

Imperial College London (Royal Brompton Hospital), London, United Kingdom.

Victoria Delgado (V)

Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

Kenneth Dickstein (K)

University of Bergen, Stavanger University Hospital, Norway.

Cecilia Linde (C)

Heart and Vascular Theme, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.

Kevin Vernooy (K)

Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center, Maastricht, and Department of Cardiology, Radboud University Medical Center (Radboudumc), Nijmegen, both in the Netherlands.

Francisco Leyva (F)

Aston Medical School, Birmingham, United Kingdom.

Johann Bauersachs (J)

Hannover Medical School, Department of Cardiology and Angiology, Hannover.

Carsten W Israel (CW)

Department of Medicine - Cardiology, Diabetology and Nephrology, Bethel-Clinic, Bielefeld, Germany.

Lars Lund (L)

Department of Medicine Karolinska Institutet, and Department of Cardiology, Karolinska, University Hospital.

Erwan Donal (E)

Cardiologie - CHU Rennes - LTSI Inserm UMR 1099 - Université Rennes-1, Rennes.

Giuseppe Boriani (G)

Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Modena, Italy.

Tiny Jaarsma (T)

Julius Center, University Medical Center Utrecht, the Netherlands and Department of Health, Medicine and Caring Science, Linköping University; Sweden.

Antonio Berruezo (A)

Heart Institute, Teknon Medical Center. Barcelona. Spain.

Vassil Traykov (V)

Department of Cardiology, Acibadem City Clinic Tokuda Hospital, Sofia, Bulgaria.

Zaheer Yousef (Z)

Department of Cardiology, University Hospital of Wales & Cardiff University.

Zbigniew Kalarus (Z)

Medical University of Silesia, Katowice, Poland Department of Cardiology.

Jens Cosedis Nielsen (J)

Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.

Jan Steffel (J)

UniversitätsSpital Zürich, Zürich, Switzerland.

Panos Vardas (P)

Heart Sector, Hygeia Hospitals Group, Athens, Greece.

Andrew Coats (A)

IRCCS San Raffaele Pisana, Rome, Italy.

Petar Seferovic (P)

Faculty of Medicine, Serbian Academy of Science and Arts, Belgrade University Belgrade, Serbia.

Thor Edvardsen (T)

Dept of Cardiology, Oslo University Hospital, Rikshospitalet, and University of Oslo, Oslo, Norway.

Hein Heidbuchel (H)

Antwerp University and Antwerp University Hospital, Antwerp, Belgium.

Frank Ruschitzka (F)

Heart and Vascular Theme, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Department of Cardiology, University Hospital, University Heart Center, Zurich, Switzerland.

Christophe Leclercq (C)

Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK.
Cardiologie - CHU Rennes - LTSI Inserm UMR 1099 - Université Rennes-1, Rennes.

Classifications MeSH